The Use of Self-reported Symptoms as a Proxy for Acute Organophosphate Poisoning Among Nepali Farmers

Organophosphate Poisoning Clinical Trial

Official title:
The Use of Self-reported Symptoms as a Proxy for Acute Organophosphate Poisoning Among Nepali Farmers: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate self-reported symptoms as a proxy for acute organophosphate poisoning by examining self-reported acute organophosphate poisoning symptoms and PchE activity in response to occupational acute organophosphate exposure among farmers in Nepal.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02838303
Study type	Interventional
Source	Bispebjerg Hospital
Contact
Status	Completed
Phase	N/A
Start date	September 2014
Completion date	November 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03564574` - To Study the Effects of Lipid Emulsion on Hemodynamics in Organophosphate Compound Poisoning	Phase 4
Completed	`NCT02147054` - A Pilot Study Using Rocuronium to Prevent Intermediate Syndrome After Organophosphorus Insecticide Poisoning	Phase 2/Phase 3
Not yet recruiting	`NCT06108557` - Paraoxonase-1 Pseudo Cholinesterase Organophosphate Toxicity Enzyme in Prediction the Severity and Outcome of Acute Organophosphate Poisoning and Its Correlation With Pseudo Cholinesterase Enzyme Level.	N/A
Completed	`NCT02137317` - Farming, Personal Protective Equipment, Nepal	N/A
Completed	`NCT02160548` - Adding Nebulized Salbutamol to Intravenous Atropine and Oxygen in OP Poisoning	Phase 3